Lutz Lingnau

Former Vice Chairman, President & Chief Executive Officer at Schering Berlin, Inc.

Lutz Lingnau

Lutz Lingnau

Former Vice Chairman, President & Chief Executive Officer at Schering Berlin, Inc.

Overview
Career Highlights

Berlex Laboratories, Inc.
Berlex Laboratory
Schering Berlin, Inc.

RelSci Relationships

125

Number of Boards

9

Birthday

03/1942

Age

76

Relationships
RelSci Relationships are individuals Lutz Lingnau likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at Nektar Therapeutics

Relationship likelihood: Strong

Founder at Numenor Ventures LLC

Relationship likelihood: Strong

Senior Vice President & Chief Operating Officer at Nektar Therapeutics

Relationship likelihood: Strong

Former Adjunct Professor-Molecular & Cellular Physiology at University of California - Davis

Relationship likelihood: Strong

Former Chief Commercial Officer & Executive Vice President at BioMarin Pharmaceutical, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer at Covance, Inc.

Relationship likelihood: Strong

Co-Founder at Incyte Corp.

Relationship likelihood: Strong

Lecturer in Management at Stanford University - Stanford Graduate School of Business

Relationship likelihood: Strong

Chief Executive Officer at Mylan Bertek Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former Chief Financial Officer & Senior Vice President at Applera Corporation

Relationship likelihood: Strong

Paths to Lutz Lingnau
Potential Connections via
Relationship Science
You
Lutz Lingnau
Former Vice Chairman, President & Chief Executive Officer at Schering Berlin, Inc.
Career History
Chairman & President
1983 - 2005
President
1983 - 2005

Berlex Laboratory

Vice Chairman, President & Chief Executive Officer
1966 - 2005

Schering Berlin, Inc., a subsidiary of Bayer AG, is a company headquartered in Whippany, NJ. The firm manufactures pharmaceuticals and diagnostic substances.

Boards & Committees
Member, Board of Directors
2007 - Current

Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. Nektar's research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates. Its drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient.

Chairman, Board of Directors
2006 - 2009

Micropharma Ltd. formulates, manufactures & sells functional food, neutraceuticals and pharmaceutical products. The company was founded by Satya Prakash in 2002 and is headquartered in North Vancouver, Canada.

Chairman, Board of Directors
2006 - 2009

Berlex Laboratory

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Lutz Lingnau. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Lutz Lingnau's profile does not indicate a business or promotional relationship of any kind between RelSci and Lutz Lingnau.